Advances in management of thalassemia.

Simple item page
dc.contributor.authorAgarwal, M Ben_US
dc.date.accessioned2009-02-14en_US
dc.date.accessioned2009-05-30T16:14:26Z
dc.date.available2009-02-14en_US
dc.date.available2009-05-30T16:14:26Z
dc.date.issued2009-02-14en_US
dc.description.abstractThalassemias represent the most common single-gene disorder causing a major public health problem in India. Thalassemia and hemoglobinopathies probably developed over 7000 years ago as a defense against malaria. In simple terms, thalassemia is caused by a mutation in either the â-globin chain or the á-globin chain which combine equally in red cells to form hemoglobin. These mutations lead to varying degree of anemia resulting into thalassemia minor, intermedia or major. Present write up relates to advances in the management of â-thalassemia major.en_US
dc.description.affiliationDepartment of Hematology, Bombay Hospital Institute of Medical Sciences, Mumbai, India. mbagarwal@hotmail.comen_US
dc.identifier.citationAgarwal MB. Advances in management of thalassemia. Indian Journal of Pediatrics. 2009 Feb; 76(2): 177-84en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/84379
dc.language.isoengen_US
dc.source.urihttps://medind.nic.in/icb/icbai.shtmlen_US
dc.subject.meshAnemia, Iron-Deficiency --genetics
dc.subject.meshBone Diseases, Metabolic --genetics
dc.subject.meshBone Diseases, Metabolic --radiography
dc.subject.meshHemoglobinopathies --genetics
dc.subject.meshHemoglobins --genetics
dc.subject.meshHemosiderosis --drug therapy
dc.subject.meshHumans
dc.subject.meshIron --adverse effects
dc.subject.meshIron Chelating Agents
dc.subject.meshPoint Mutation --genetics
dc.subject.meshThalassemia --genetics
dc.subject.meshThalassemia --therapy
dc.titleAdvances in management of thalassemia.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Pediatrics